Loading
UCB
UCB is a Brussels pharmaceutical company focused on neurology and immunology whose cancer trials on the registry are mostly older programmes and supportive care studies.
Also called: UCB Biopharma SRLUCB PharmaUCB S.A.UCB Biopharma S.P.R.L.UCB BiopharmaRa Pharmaceuticals, Inc.
· 1 more · Fewer names
Ra Pharmaceuticals
Overview
UCB is a Belgian biopharmaceutical company, listed on Euronext Brussels, whose marketed medicines are in epilepsy, immunology and rare diseases. Its subsidiaries UCB Biopharma SRL and UCB Pharma appear as lead sponsors of a number of phase 3 cancer trials on ClinicalTrials.gov, largely from earlier programmes and studies of supportive medicines; oncology is not part of its current core strategy. OnCo records it so that those trials resolve to a sponsor page.
Connected
4Similar pages
- CompanyPregLem
- CompanyAgennix
- CompanyLisata Therapeutics
- CompanyImmunitor
- CompanyEmergent BioSolutions
- CompanyHarbour BioMed
- CompanyCyclacel Pharmaceuticals
- CompanyVion Pharmaceuticals
Sources
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
ClinicalTrials.gov · 1
ucb.com · 1
Wikipedia · 1
A source that has moved or gone is reported by the weekly link check. /audit/